本頁面由Tiger Trade Technology Pte. Ltd.提供服務

C4 Therapeutics, Inc.

3.44
-0.0100-0.29%
成交量:49.10萬
成交額:170.98萬
市值:4.23億
市盈率:-3.79
高:3.59
開:3.51
低:3.43
收:3.45
52周最高:5.17
52周最低:1.69
股本:1.23億
流通股本:9,451.50萬
量比:0.87
換手率:0.52%
股息:- -
股息率:- -
每股收益(TTM):-0.9085
每股收益(LYR):-1.2666
淨資產收益率:-48.14%
總資產收益率:-19.25%
市淨率:1.71
市盈率(LYR):-2.72

資料載入中...

2022/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/08

重要事件披露

8-K - Current report
2022/03/16

重要事件披露

8-K - Current report
2022/02/24

重要事件披露

8-K - Current report
2022/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/21

重要事件披露

8-K/A [Amend] - Current report
2022/01/10

重要事件披露

8-K - Current report
2021/11/19

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/15

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/12

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/05

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/11

重要事件披露

8-K - Current report
2021/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/06/21

重要事件披露

8-K - Current report